Clarus Therapeutics HoldingsCRXTQ
13F holders, Q4 2025 (December 31)1holders
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Clarus Therapeutics Holdings (CRXTQ) in their 13F filings. The largest holder was Garton & Associates Financial Advisors LLC ($0).
- Company
- Clarus Therapeutics Holdings
- CUSIP
- 18271L107
- Latest filing quarter
- Q4 2025
Total Exit/New Position Q4 2025
No earlier quarter to compare with.
Ownership 1 holders
| Garton & Associates Financial Advisors LLC | 0.00% | — | 25,354 | $0 |
"% of holder's portfolio" is CRXTQ's weight in each manager's 13F, not the share of Clarus Therapeutics Holdings the manager owns.